David Spaight has been appointed chief executive officer of WIL Research Company. He will also join the board of directors. Mr. Spaight will oversee the company’s four major businesses: WIL Research Labs, NOTOX, Midwest BioResearch and QS Pharma. He will continue to implement a long-term strategy of integrating the businesses to provide greater value and full service to clients across the globe. Mr. Spaight has more than 25 years of experience in the life and analytical sciences industry, as ...